2m 2m 2m 2m 2m 2m 2m
REVELATN BIO (REVB)
NASDAQ
$0.99+$0.0006 (+0.06%)
Price as of Sep 11, 2026 7:30 PM EDT- $4.0MMarket Cap
- -87.08%1-Year Change
- BiotechnologyIndustry
REVELATN BIO (REVB)
$0.99+$0.0006 (+0.06%)
REVB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.99 | ||
Change | -$0.007 (-0.71%) | ||
Open | $1.00 | ||
High | $1.00 | ||
Low | $0.99 | ||
Previous Close | $1.00 | ||
Volume | 3,617 | ||
30-Day Average Volume | 37,422 | ||
1-Week Change | -1.74% | ||
1-Month Change | -12.18% | ||
1-Year Change | -87.08% | ||
3-Year Change | -99.98% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 4.0M | ||
Total Assets | $12.5M | ||
Market Cap | $4.0M | ||
Enterprise Value | -$7.5M | ||
Period: QTR TTM FY | |||
Revenue | $82,159.00 | ||
Net Income | -$3.3M | ||
Free Cash Flow | -$2.6M | ||
EBIT | -$3.3M | ||
EBITDA | -$3.3M | ||
Net Working Capital | $9.8M | ||
EPS | -$0.87 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | -92 | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 01/28/2026 | ||
Earnings & Revenue